Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

824 ARTÍCULOS , VIENDO DEL 721 AL 735

Optical coherence tomography as retinal imaging biomarker of neuroinflammation/neurodegeneration in systemic disorders in adults and children

Vujosevic S, Parra MM, Hartnett ME, O'Toole L, Nuzzi A, Limoli C, Villani E, Nucci P.

Eye (Lond). 2023 Feb;37(2):203-219. doi: 10.1038/s41433-022-02056-9. Epub 2022 Apr 15.

Mesenchymal Stem Cell Therapy in the Treatment of Neurodegenerative Cerebellar Ataxias: a Systematic Review and Meta-analysis

Bhartiya M, Kumar A, Singh RK, Radhakrishnan DM, Rajan R, Srivastava AK.

Cerebellum. 2023 Jun;22(3):363-369. doi: 10.1007/s12311-022-01403-6. Epub 2022 Apr 22.

Autoimmune Cerebellar Ataxia: Etiology and Clinical Characteristics of a Case Series from China

Liu M, Ren H, Zhu Y, Fan S, Bai L, Wang J, Cui L, Guan H.

Cerebellum. 2023 Jun;22(3):379-385. doi: 10.1007/s12311-022-01412-5. Epub 2022 May 26.

M1 and Cerebellar tDCS for MSA-C: a Double-Blind, Randomized, Sham-Controlled, Crossover Study

Ahn JH, Lee D, Kim M, Cho JW, Chang WH, Youn J.

Cerebellum. 2023 Jun;22(3):386-393. doi: 10.1007/s12311-022-01416-1. Epub 2022 May 28.

ANO10 Function in Health and Disease

Chrysanthou A, Ververis A, Christodoulou K.

Cerebellum. 2023 Jun;22(3):447-467. doi: 10.1007/s12311-022-01395-3. Epub 2022 Jun 1.

Episodic Ataxia Type 1: Natural History and Effect on Quality of Life

Graves TD, Griggs RC, Bundy BN, Jen JC, Baloh RW, Hanna MG; CINCH Investigators.

Cerebellum. 2023 Aug;22(4):578-586. doi: 10.1007/s12311-021-01360-6. Epub 2022 Jun 3.

Using animal models to identify clinical risk factors in the older population due to alcohol use and misuse

Matthews DB, Rossmann G.

Alcohol. 2023 Mar;107:38-43. doi: 10.1016/j.alcohol.2022.05.003. Epub 2022 Jun 2.

Cholecystokinin Activation of Cholecystokinin 1 Receptors: a Purkinje Cell Neuroprotective Pathway

Orr HT.

Cerebellum. 2023 Aug;22(4):756-760. doi: 10.1007/s12311-022-01428-x. Epub 2022 Jun 23.

Delayed Appearance of Brain Magnetic Resonance Imaging Abnormalities in a Patient with Glial Fibrillary Acidic Protein Astrocytopathy

Izumi M, Uzawa A, Aoki R, Suzuki M, Yoshizawa K, Suzuki Y, Kimura A, Shimohata T, Kuwabara S.

Intern Med. 2023 Feb 1;62(3):465-468. doi: 10.2169/internalmedicine.9724-22. Epub 2022 Jul 5.

Psychiatric symptoms in Salla disease

Aulanko I, Rahikkala E, Moilanen J.

Eur Child Adolesc Psychiatry. 2023 Oct;32(10):2043-2047. doi: 10.1007/s00787-022-02031-5. Epub 2022 Jul 7.

Possible Chronic Graft-versus-host Disease in the Central Nervous System Manifesting as Cerebellar Ataxia after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

Takahashi K, Katayama T, Ichikawa T, Matsuoka S, Kakinoki Y, Yoneda M, Kimura A, Koyama S, Yahara O.

Intern Med. 2023 Mar 1;62(5):779-786. doi: 10.2169/internalmedicine.9720-22. Epub 2022 Aug 10.

Symptomatic atherosclerotic plaque accompanied by carotid web

Kasashima K, Fujimoto M, Tani S, Ogata H, Shimizu K, Itani M, Akiyama Y.

Neuroradiol J. 2023 Apr;36(2):220-223. doi: 10.1177/19714009221122192. Epub 2022 Aug 19.

A Review on the Clinical Diagnosis of Multiple System Atrophy

Stankovic I, Fanciulli A, Sidoroff V, Wenning GK.

Cerebellum. 2023 Oct;22(5):825-839. doi: 10.1007/s12311-022-01453-w. Epub 2022 Aug 19.

A De Novo HECW2 Variant in a Patient with Acetazolamide-Responsive Episodic Ataxia

Tedesco Silva LM, Sharma S, Schrauwen I, Margolesky J, Detyniecki K.

Cerebellum. 2023 Oct;22(5):1029-1033. doi: 10.1007/s12311-022-01458-5. Epub 2022 Aug 20.

Dentatorubropallidoluysian Atrophy with Prominent Autonomic Dysfunction

Shioya A, Takuma H, Ohkoshi N, Hirano K, Ishihara T, Ishii K, Tamaoka A.

Intern Med. 2023 Mar 15;62(6):889-892. doi: 10.2169/internalmedicine.9616-22. Epub 2022 Aug 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias